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This study evaluated the antifungal action of biomolecules produced from the secondary metabolism of 
bacterial strains found in the rhizosphere of semi arid plants against human pathogenic Candida 
albicans. Crude extracts were obtained using ethyl acetate as an organic solvent and the bioactivity was 
assessed with a bioautography technique. The results showed that bacterial strains, Alcaligenes 
faecalis MRbS12 and Bacillus cereus MRbS26, had compounds with antifungal bioactivity. The largest 
inhibition zones for both compounds were located on spots with Rf values below 0.500, indicating that 
the molecules possibly had polar characteristics. These results suggested that microorganisms found 
in the environment could have bioprospecting potential. 
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INTRODUCTION 
 
In the last decade, increasingly invasive mycosis has 
become a public health problem. This increased inci-
dence is related to human immunodeficiency virus (HIV), 
hematological malignancies, organ transplants and other 
immunosuppressive diseases. Fungal infections remain 
the major direct cause of death in patients who are 
treated for malignant diseases, where the emergence of 
fungal resistances is also a prominent issue. Immuno-
compromised patients are mainly infected by Candida, 
Aspergillus, Cryptococcus and other opportunistic fungi. 
Candida albicans is often associated with serious inva-
sive fungal infections, but Candida species and yeast-like 
organisms (Trichosporon, Blastoschizomyces and 
Malassezia)   have   emerged   as   etiological   agents  in  
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several mycoses (Anaissie, 1992; Carrillo-Muñoz et al., 
2001; Ghannoum and Abu-Eltenn, 1990; Ghannoum and 
Rice, 1999; Kauffman, 2001) 
Moreover, the treatment of fungal infections has been 
limited due to low drug efficacy, fungal resistance and 
pharmacological safety in regards to the existing 
pharmaceutical drugs in the market, such as amphotericin 
B, fluconazole and itraconazole, among others. These 
findings reinforce the growing need for bioprospection of 
new drugs with specific antifungal activity. Furthermore, 
increased demographic trends strongly suggest that the 
number of fungal infections are and will continue to 
increase, especially due to the aging of populations in 
developed countries (Barret, 2002; Carrillo-Muñoz, 2000; 
Odds, 2005; Anaissie, 1992). 
It now appears that an enormous, relatively untapped 
source of microbial diversity is represented by microbes 
associated with plants. These microorganisms produce 
antimicrobial  agents  and  seem  to  have unique genetic  
  
 
 
 
and biological systems that may have applications 
outside the host plants, in which they normally reside. 
Bioprospection of such organisms and their products 
represents a promising source in the discovery of new 
antifungal drugs, which could be applied in the pharma-
ceutical industry (Colwell, 1997; Demain, 2000; Strobel, 
2003). This study was aimed to determine the antifungal 
activity against the human pathogen, C. albicans (CCMB 
286), found in biomolecules obtained from bacterial 
strains of the rhizosphere of Stachytarpheta crassifolia, 
collected in Chapada Diamantina, Bahia, Brazil. 
 
 
MATERIALS AND METHODS 
 
Plants used and the rhizobacterial isolation 
 
Two rhizobacterial strains, MRbS12 and MRbS26, were selected 
from a total of 32 strains previously isolated from S. crassifolia in 
Chapada Diamantina, Bahia, Brazil, (S13°00’06”, W41°20’33.7”). 
These strains were subjected to in vitro screening to evaluate the 
antifungal activity of their secondary metabolites. The isolate was 
identified by sequencing the 16S rDNA region. Genomic DNA was 
extracted using the phenol-chloroform-isoamyl alcohol (25:24:1) 
protocol, as described by Sambrook et al. (2001). The following 
primers were used for PCR amplification of the 16S ribosomal DNA: 
fD1 (5'-AGAGTTTGATCCTGGCTCAG-3') and rP2 (5'-
ACGGCTACCTTGTTACGACTT-3') (Weisburg et al., 1991). The 
sequence obtained in this study was deposited to the GenBank 
nucleotide sequence database under the access number FJ959394 
for Alcaligenes faecalis (MRbS12) and FJ959395 for Bacillus 
cereus (MRbS26). 
 
 
Extraction procedure 
 
To obtain the crude extract, an adapted protocol of Kilikian and 
Pessoa (2001) was used. The strains were inoculated in 1000 ml of 
nutrient broth, incubated at 37°C, at 180 rpm for 72 h and the 
supernatant was filter-sterilized by a vacuum filtration system 
(Sartorius of 0.45 µm milipore; Frankfurt, Germany).  The filtrates 
were then liquid-liquid extracted in two-phase aqueous systems 
(SDFA) with the solvent ethyl acetate (PA, Vetec, Rio de Janeiro, 
Brazil) at a ratio of 1:1 (v/v). The organic phase was added to 5% 
anhydrous sodium sulphate (PA - Vetec, Rio de Janeiro, Brazil) and 
was concentrated in a rotary evaporator (Quimis, São Paulo, Brazil) 
at 45°C, under reduced pressure. The dried crude extract used as 
negative control, was obtained by extraction from the nutrient broth 
in ethyl acetate without the inoculum. 
 
 
Antifungal activity 
 
Thin-layer chromatography  
 
This was performed to aid in the selection for the appropriate 
solvent system for the bioautography and also to provide relevant 
information of the chemical properties of the bacterial metabolites.  
Aluminum chromatoplate (TLC1, 5 x 8.0 in silica gel 60 F254-366, 
0.25 mm thick - Merck, Darmstadt, Germany) was used during this 
procedure. Elution was performed with the use of solvent systems 
(mobile phase), ethyl acetate/hexane (7:3 v/v), and then were 
revealed under ultraviolet light (UV, 366 nm) for compounds, where 
visualization and resublimation was performed in an iodine 
chamber  for  qualitative  analysis.  The  migration  distance   of  the  
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spots of the extracts was analyzed by calculating the retention rate 
(Rf). 
 
 
Fungal test organisms 
 
Initially, the experiment was performed with three fungal strains of 
C. albicans (CCMB242, CCMB 265 and CCMB286) for bioassay, 
however, the strain was selected and C. albicans CCMB286 
devised its viability and performance. The fungal pathogens were 
obtained from the Culture Collection of Microorganisms of Bahia 
(CCMB), State University of the Feira de Santana, BA, Brazil. The 
strains were clinical isolates from the urine clinical sample and were 
maintained on Sabouraud dextrose agar (SAB, Himedia, Bombay, 
India). 
 
 
Bioautography  
 
The bioautography technique, using thin layer chromatography 
(TLC), was proposed by Romeiro (2001), who presented an 
adapted method to that of Hamburguer and Cordell (1987).  
Petri dishes containing 2% water agar, were prepared and added 
to a chromatoplate with their extracts eluted. Then, Sabouraud 
dextrose agar was also added to the culture medium, which was 
composed of 0.8% 20 mg/ml-1 chloride 2,3,5-triphenyl-2H-
tetrazolium (CTT) and 2.5 ml of the suspended cells from stain C. 
albicans CCMB 286, corresponding to the turbidity of 0.5 on the 
McFarland scale (equivalent to 1.5.106 CFU/ml) (McFarland, 1907), 
and scattered onto the chromatoplates. The plates were incubated 
at 37°C for 72 h. Zones of inhibition were then visualized by 
dehydrogenase activity detecting tetrazolium salt. Metabolically, 
fungal activity converts the tetrazolium salt into the corresponding 
intensely red colour. Thus, antifungal compounds appear as clear 
spots against a colored background. The results were obtained by 
bioautography, in conjunction with UV light visualization 
(wavelength, 366 nm), where the retention rate and the band width 
of the active compound inhibition zones (LB) were determined. All 
tests were performed in triplicate for each extract and the reference 
extract (crude extract of the medium without inoculum) was used as 
the negative control and Nystatin® was used as the standard 
control drugs for C. albicans. 
 
 
RESULTS 
 
The strains, MRbS12 and MRb26, demonstrated 
biomolecule production with antifungal activity against C. 
albicans CCMB286. Such strains were identified by 
partial sequencing of the 16S rRNA. Based on this gene 
fragment analysis, with approximately 1400 bp and simi-
larity values of 99%, the following strains were identified: 
A. faecalis (MRbS12) and B. cereus (MRbS26). 
 
 
Antifungal activity determination 
 
The purpose of this research was to determine the anti-
microbial biomolecule production, which presents biological 
control mechanisms against C. albicans. The presence of 
11 spots was detected in the Ex12 extract, eluted in the 
ethyl acetate/hexane solvent system 9:1, and the Ex26 
extract, eluted in the ethyl acetate/hexane 7:3 and with 
ten drops of methanol. All of them were visible under UV 
at 366 nm in the iodine chamber.  
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Figure 1. Summary of the distribution of compounds and fungal inhibition 
zones from the bacteria extracts applied to thin layer chromatography plates 
and developed in the extracts Ex12 (eluted in ethyl acetate/hexane 9:1), Ex18, 
Ex26 and ExCN (eluted in ethyl acetate/hexane 7:3 and 10 drops of methanol). 
Ultraviolet detection was at 366 nm. Compounds were indicated by circles at 
the Rf where they were detected. The active compounds against C. albicans 
are in black. 
 
 
 
Antifugal spots analysis 
 
Figure 1 shows the bioautography plate with inhibition 
zones and Figure 2 presents the summarized results of 
the TLC bioautography, where filled spots indicate the 
presence of antifungal compounds. The control extract 
from the non-inoculated NA showed no activity. In a 
chromatogram, the spots mean groups of the compounds 
are separated by differences in polarity. Spots next to the 
origin are the polar groups of the substances; whereas 
those closer to the end of the running eluent, are non-
polar components (Burkhead et al., 1995; Aquino and 
Nunes, 2003). 
In this study, the largest inhibition zones were on the 
spots below the Rf value of 0.500, indicating that the 
molecules with greater activity probably had polar 
characteristics and intermediate polarity. The inhibition 
zones of the extracts Ex12 of A. faecalis (MRbS12) were 
spots with Rf values of 0.043, 0.085 and 0.430; and the 
values of the Ex26 of B. cereus were 0.071, 0.214, 0.400 
and 0.750 (Table 1). Only two antifungal compounds 
were detected above Rf 0.700. These compounds were 
present at Rf 0.970 for MRbS12, and at Rf 0.750 for 
MRbS26, according to the extraction conditions used, 
which was considered to have more nonpolar compound 
extracts. The control tests with solvent and extract from 
uninoculated nutrient broth showed no zones of inhibition. 
Although specific experiments related to the stability of 
the biomolecules have not been performed, it was observed 
that crude extract, when maintained by refrigeration (until 
approximately eight months at -4°C), kept its antifungal 
activity, demonstrating stability under these conditions. 
All antifungal compounds were associated with distinct 
spots, which had been detected under UV radiation.  
 
 
DISCUSSION 
 
Bioautography allows easy activity detection even in 
complex mixtures and is a method to detect antifungal 
activity on a chromatogram. This approach has wide 
application in the search for new antibiotics. The main 
purpose of the assay was to suspend microorganisms in 
a suitable broth to develop a TLC plate. Incubation in a 
humid atmosphere allows fungal inhibition zone growth 
that can then be viewed by dehydrogenase activity, using 
a tetrazolium salt reagent. Thus, antifungal compounds 
appear as clear spots against a colored background 
(Hamburguer and Cordell, 1987; Burkhead et al., 1995). 
In this study, such a technique was considered efficient 
and sensitive enough to determine the antifungal activity 
of the biomolecules obtained from rhizobacteria, collected 
from the S. crassifolia rizosphere. It was possible to 
observe the activity of the different substances separated  
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Figure 2. Section from bioautography plates of the extracts from the selected rhizobacteria to 
determine the antifungal activity. The clear areas correspond to the cell growth inhibition halos of 
Candida albicans. 
 
 
 
Table 1. Crude extracts with antifungal activity, their Rfs and the extent of WA inhibition area in mm. 
 
Crude extract Rf with activity WA (mm) Concentration(mg/10 µl) 
Ex12 
0.043; 0.085* 
0.400 
0.430 
0.970 
8 
2 
2 
4 
4.75 
    
Ex18 - - 3.48 
    
Ex26 
0.071; 0.214* 
0.400 
0.740 
10 
2 
3 
4.18 
    
ExCn - - 5.75 
 
*Rfs comprising the same inhibition zone; (-) lack of inhibition; ExCn, negative control. 
 
 
 
from the original extract on a single chromatographic 
plate, even with compounds of low concentration. As indi-
cated in the research by Homans and Fuchs (1970), 
Hamburguer and Cordell (1987) and Magalhães et al. 
(2007), bioautography is a technique for easy application 
and fast detection of antifungal compounds obtained from 
secondary metabolites of microorganisms and plants, 
especially against Aspergillus niger, Colletotrichum linde, 
Fusarium cingulata and C. albicans. 
According to the study by Bacic and Yoch (2008), 
filtrate from strains of A. faecalis, isolated from a swamp 
substrate, presented antimicrobial activity against both 
Gram-negative  and positive bacteria. Honda et al. (1998) 
found antifungal activity against Fusarium oxysporum in 
the eluted A. faecalis, isolated from the rhizosphere, 
which corroborates with the findings of this study. Other 
authors such as Tripathi et al. (2000) and Melo (2002), 
showed that the strain of this species also produces 
compounds that can be of industrial use in the production 
of D-aminocyclases, semi-synthetic antibiotics (penicillin 
and cephalosporin), hormones (lutein), bioactive peptides 
and chemical pesticides. Also, the species can syn-
thesize compounds with antagonistic action against plant 
pathogen nematodes (Tian et al., 2007). The research by 
Idris et al. (2007) demonstrated the antifungal acti-vities 
of  B. cereus  filtrate,   obtained  from  the  rhizosphere  of  
 5000         Afr. J. Biotechnol. 
 
 
 
Sorghum bicolor, against Fusarium oxysporum. Milner et 
al. (1996) observed that strains of Bacillus have com-
pounds with antifungal properties. Other authors reported 
that B. cereus significantly influences the microbial 
community of the rhizosphere by stimulating the growth 
of other bacteria that promote plant growth, as well as 
acting against plant pathogens. These species can be 
used as biological controls (Lambert et al., 1987; Kumar 
et al., 2002; Fortes et al., 2006). Kishore and Pande 
(2007) tested the antifungal activity of B. cereus against 
Botrytis cinerea in vitro and in vivo, using cellular suspen-
sion, and concluded that the compound exhibited 
antifungal activity. Later, the compound was recognized 
as chitinase, which degraded the fungal cell wall. The 
strains, A. faecalis (MRbS12) and B. cereus (MRbS26), 
isolated from the rhizosphere of S. crassifolia, were able 
to produce compounds with antifungal properties against 
C. albicans CCMB286. The results obtained in this study 
showed that secondary metabolites from rhizobacteria 
had antifungal potential and can be considered as 
promising sources of bioprospection to the pharma-
ceutical industry. Moreover, this work is the first scientific 
report for the secondary metabolites of bacterial strains 
associated with plants from the Brazilian semi-arid 
region.  
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